Marshall Wace
SGNT

Marshall Wace’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Marshall Wace’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-81,284
Closed -$1.98M – 1180
2015
Q2 		$1.98M Buy
+81,284
New +$1.95M 0.03% 480

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's SGNT Position: Q3 2015 in Review

Marshall Wace sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 81,284 shares — an estimated $1.98M sold.

Marshall Wace first reported a position in SGNT in Q2 2015 and held it in 1 quarter. The position peaked at $1.98M in Q2 2015. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • Marshall Wace reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Marshall Wace sold 81,284 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $1.98M.
  • Marshall Wace first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 1 quarter.
  • Marshall Wace's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.98M in Q2 2015.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.